Cargando…

GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker

Glucosamine-phosphate N-acetyltransferase 1 (GNPNAT1) is a member of the acetyltransferase superfamily, related to general control non-depressible 5 (GCN5). It has been documented that GNPNAT1 expression is increased in lung cancer, whereas its involvement in breast cancer (BC) remains to be further...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Hao, Wang, Zhi-Wen, Hu, Shuang, Xiang, Yuan, Deng, Yang, Wan, Fu-Jian, Zhang, Tong-Cun, Yang, Zhong-Yi, Liao, Xing-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326828/ https://www.ncbi.nlm.nih.gov/pubmed/37387422 http://dx.doi.org/10.3892/or.2023.8594

Ejemplares similares

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma
por: Zheng, Xiangyu, et al.
Publicado: (2020)

GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer
por: Yuan, Renjie, et al.
Publicado: (2023)

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Liu, Wenting, et al.
Publicado: (2021)

GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer
por: Feng, Yong, et al.
Publicado: (2022)

Nanoparticle abraxane possesses impaired proliferation in A549 cells due to the underexpression of glucosamine 6-phosphate N-acetyltransferase 1 (GNPNAT1/GNA1)
por: Zhao, Minzhi, et al.
Publicado: (2017)

CDK1 serves as a potential prognostic biomarker and target for lung cancer
por: Li, Mingyao, et al.
Publicado: (2020)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)

Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia
por: Wei, Jie, et al.
Publicado: (2021)

TEADs serve as potential prognostic biomarkers and targets for human gastric cancer
por: Wang, Meng-huan, et al.
Publicado: (2022)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2017)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022)

LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic role in retinoblastoma
por: Hao, Fengqin, et al.
Publicado: (2018)

Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer
por: Zhou, Wei-hua, et al.
Publicado: (2011)

GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival
por: Yang, Dingquan, et al.
Publicado: (2020)

Glycosylated Cathepsin V Serves as a Prognostic Marker in Lung Cancer
por: Yang, Lewei, et al.
Publicado: (2022)

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021)

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
por: Zhu, Xudong, et al.
Publicado: (2020)

Circulating TP73‐AS1 and CRNDE serve as diagnostic and prognostic biomarkers for non‐small cell lung cancer
por: Yuan, Rong‐Xia, et al.
Publicado: (2022)

Inflammation-Related Genes Serve as Prognostic Biomarkers and Involve in Immunosuppressive Microenvironment to Promote Gastric Cancer Progression
por: Wei, Yuanfeng, et al.
Publicado: (2022)

Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma
por: Yang, Jian, et al.
Publicado: (2022)

Dysregulated Expression of Circular RNAs Serve as Prognostic and Clinicopathological Markers in Cancer
por: Huang, Xin, et al.
Publicado: (2019)

Long non-coding RNA AC023794.4-201 exerts a tumor-suppressive function in laryngeal squamous cell cancer and may serve as a potential prognostic biomarker
por: Shen, Zhisen, et al.
Publicado: (2020)

N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker
por: Teng, Yin, et al.
Publicado: (2023)

ZW10 interacting kinetochore protein may serve as a prognostic biomarker for human breast cancer: An integrated bioinformatics analysis
por: Li, Han-Ning, et al.
Publicado: (2020)

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma
por: Xu, Guang-hua, et al.
Publicado: (2018)

Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer
por: Xie, Yuan, et al.
Publicado: (2017)

LncRNA ZFAS1 serves as a prognostic biomarker to predict the survival of patients with ovarian cancer
por: Han, Shuang, et al.
Publicado: (2019)

UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer
por: Sun, Qiran, et al.
Publicado: (2023)

OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer
por: Mao, Min, et al.
Publicado: (2021)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia
por: Li, Fenglin, et al.
Publicado: (2023)

Autophagic Protein Beclin 1 Serves as an Independent Positive Prognostic Biomarker for Non-Small Cell Lung Cancer
por: Zhou, Weihua, et al.
Publicado: (2013)

Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer
por: Yang, Xiaochen, et al.
Publicado: (2021)

Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma
por: Zhang, Yi, et al.
Publicado: (2014)

SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Liu, Gaohua, et al.
Publicado: (2022)

Extra Spindle Pole Bodies-Like 1 Serves as a Prognostic Biomarker and Promotes Lung Adenocarcinoma Metastasis
por: Nie, Zhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j9jifipj3k7ebm282if1hv1qv6